Piazza, Gregory http://orcid.org/0000-0003-1407-5276
Hurwitz, Shelley
Carroll, Brett
Goldhaber, Samuel Z.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Patients with perceived high-bleeding risk and computerized decision support for stroke prevention in atrial fibrillation: an AF-ALERT substudy
https://doi.org/10.1007/s11239-020-02296-0
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Accepted: 26 September 2020
First Online: 30 September 2020
Compliance with ethical standards
:
: Dr. Piazza has received research support from Bristol-Myers Squibb, Bayer, Janssen, Portola, and BTG and consulting fees from Pfizer, Bayer, Janssen, Agile, Amgen and Portola. Dr. Goldhaber has received research support from Boehringer Ingelheim, Bristol-Myers Squibb, EKOS, a BTG International Company, Johnson & Johnson, and Janssen and consulting fees from Boehringer Ingelheim, Bayer, and Agile. Drs. Hurwitz and Carroll have no conflicts of interest to disclose.
: The study was approved by the Institutional Review Board of Partners HealthCare System.
: The Institutional Review Board waived the requirement of informed consent.
: All authors have approved submission of this manuscript.